Immunohistochemical analysis was carried out to assess the expression of RANKL, RANK, and OPG in primary NSCLC tumors, as well as in bone metastatic tissues of NSCLC. This evidence concerns the gene TNFRSF11A and non-small cell lung carcinoma.